Rtw Investments as of June 30, 2023
Portfolio Holdings for Rtw Investments
Rtw Investments holds 62 positions in its portfolio as reported in the June 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Immunocore Hldgs Ads (IMCR) | 6.9 | $362M | 6.0M | 59.96 | |
Rocket Pharmaceuticals (RCKT) | 6.7 | $352M | 18M | 19.87 | |
Alnylam Pharmaceuticals (ALNY) | 6.1 | $320M | 1.7M | 189.94 | |
Axsome Therapeutics (AXSM) | 5.9 | $308M | 4.3M | 71.86 | |
Ptc Therapeutics I (PTCT) | 5.6 | $294M | 7.2M | 40.67 | |
Ultragenyx Pharmaceutical (RARE) | 4.7 | $249M | 5.4M | 46.13 | |
Masimo Corporation (MASI) | 4.7 | $247M | 1.5M | 164.55 | |
ACADIA Pharmaceuticals (ACAD) | 4.5 | $234M | 9.8M | 23.95 | |
Penumbra (PEN) | 4.4 | $232M | 673k | 344.06 | |
Bruker Corporation (BRKR) | 4.2 | $219M | 3.0M | 73.92 | |
Argenx Se Sponsored Adr (ARGX) | 3.6 | $188M | 482k | 389.73 | |
Establishment Labs Holdings Ord (ESTA) | 3.3 | $171M | 2.5M | 68.61 | |
Mirati Therapeutics | 3.1 | $162M | 4.5M | 36.13 | |
Thermo Fisher Scientific (TMO) | 2.9 | $152M | 290k | 521.75 | |
Protagonist Therapeutics (PTGX) | 2.8 | $150M | 5.4M | 27.62 | |
Natera (NTRA) | 2.4 | $127M | 2.6M | 48.66 | |
Vericel (VCEL) | 2.4 | $124M | 3.3M | 37.57 | |
Celldex Therapeutics Com New (CLDX) | 2.2 | $118M | 3.5M | 33.93 | |
Avadel Pharmaceuticals Sponsored Adr | 2.1 | $112M | 6.8M | 16.48 | |
Horizon Therapeutics Pub L SHS | 2.0 | $103M | 1.0M | 102.85 | |
Cytokinetics Com New (CYTK) | 1.6 | $84M | 2.6M | 32.62 | |
10x Genomics Cl A Com (TXG) | 1.6 | $82M | 1.5M | 55.84 | |
Avidity Biosciences Ord (RNA) | 1.4 | $74M | 6.7M | 11.09 | |
Illumina (ILMN) | 1.3 | $71M | 376k | 187.49 | |
Intuitive Surgical Com New (ISRG) | 1.1 | $58M | 170k | 341.94 | |
Madrigal Pharmaceuticals (MDGL) | 1.0 | $51M | 222k | 231.00 | |
Stoke Therapeutics (STOK) | 0.9 | $47M | 4.4M | 10.63 | |
Tarsus Pharmaceuticals (TARS) | 0.9 | $46M | 2.5M | 18.07 | |
Axonics Modulation Technolog (AXNX) | 0.9 | $45M | 885k | 50.47 | |
Health Sciences Acq Corp 2 (OBIO) | 0.7 | $39M | 5.6M | 7.00 | |
Scpharmaceuticals (SCPH) | 0.6 | $34M | 3.3M | 10.19 | |
Cutera (CUTR) | 0.5 | $28M | 1.8M | 15.13 | |
Merus N V (MRUS) | 0.5 | $28M | 1.1M | 26.33 | |
Gh Research Ordinary Shares (GHRS) | 0.5 | $26M | 2.2M | 11.87 | |
Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.5 | $26M | 500k | 51.00 | |
Insmed Com Par $.01 (INSM) | 0.4 | $21M | 1.0M | 21.10 | |
Acelyrin (SLRN) | 0.4 | $20M | 978k | 20.90 | |
Fulcrum Therapeutics (FULC) | 0.4 | $20M | 6.1M | 3.30 | |
Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.4 | $19M | 1.5M | 12.43 | |
Pmv Pharmaceuticals (PMVP) | 0.4 | $19M | 3.0M | 6.26 | |
Guardant Health (GH) | 0.3 | $18M | 501k | 35.80 | |
Outset Med (OM) | 0.3 | $18M | 809k | 21.87 | |
Viking Therapeutics (VKTX) | 0.3 | $16M | 1.0M | 16.21 | |
Mineralys Therapeutics (MLYS) | 0.3 | $16M | 922k | 17.05 | |
Roivant Sciences SHS (ROIV) | 0.3 | $16M | 1.6M | 10.08 | |
Olink Hldg Ab Sponsored Ads (OLK) | 0.2 | $12M | 655k | 18.75 | |
Immunic (IMUX) | 0.2 | $11M | 4.3M | 2.51 | |
Adicet Bio (ACET) | 0.2 | $10M | 4.2M | 2.43 | |
Design Therapeutics (DSGN) | 0.2 | $9.8M | 1.6M | 6.30 | |
Immatics SHS (IMTX) | 0.2 | $9.8M | 845k | 11.54 | |
Milestone Pharmaceuticals (MIST) | 0.2 | $9.3M | 3.3M | 2.85 | |
Apyx Medical Corporation (APYX) | 0.2 | $8.9M | 1.8M | 5.03 | |
Urogen Pharma (URGN) | 0.2 | $8.9M | 858k | 10.35 | |
Black Diamond Therapeutics (BDTX) | 0.2 | $8.6M | 1.7M | 5.05 | |
Dermtech Ord ord (DMTKQ) | 0.1 | $7.1M | 2.7M | 2.60 | |
Relmada Therapeutics (RLMD) | 0.1 | $5.2M | 2.1M | 2.46 | |
Exagen (XGN) | 0.1 | $4.3M | 1.5M | 2.90 | |
Akoya Biosciences (AKYA) | 0.0 | $2.5M | 338k | 7.39 | |
Mersana Therapeutics (MRSN) | 0.0 | $2.0M | 615k | 3.29 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $1.3M | 128k | 10.53 | |
Miromatrix Med | 0.0 | $779k | 445k | 1.75 | |
Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $67k | 350k | 0.19 |